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Renal binding sites for labelled salmon calcitonin (sCT) were studied using cryostat sections and autoradio- 
graphy. Increasing concentrations of unlabelled sCT inhibited *2SI-sCT binding. 1Z5I-sCT bound to a single 
site with a & of 2 nM and a number of sites of 220 fmol/mg protein. Mammalian calcitonins had low 
affinities and peptides unrelated to CT were devoid of any significant affinity for izSI-sCT receptors. Auto- 
radiograms disclosed a high concentration of 1251-sCT receptors mainly located in the outer medulla and 
heterogeneously in the renal cortex. The distribution of specific binding sites is in agreement with the current 
concepts of renal action of calcitonin. 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Calcitonin [l], one of the 3 major hormonal 
regulators of calcium metabolism, interacts with 
specific receptors in kidney and bone [2-51. Loca- 
lization of these binding sites has relied upon the 
activation of adenylate cyclase in isolated mammal- 
ian nephron [4,7] or on autoradio~aphi~ studies 
following in vivo administration of labelled salmon 
calcitonin [8]. However, these approaches did not 
allow easy quantitation of the binding sites. 
2.1. Hormones and chemicafs 
We have carried out quantitative in vitro auto- 
radiography [9,10] on rat kidney cryostat sections 
to localize and quantitate c~citonin-binding sites. 
Synthetic salmon calcitonin (sCT, biological ac- 
tivity 4000 U/mg; batch no. 2005 1) was kindly sup- 
plied by Sandoz, Basle (Switzerland) and iodinated 
by the chloramine-T method [ll] to a specific ac- 
tivity of 490 Cilg. Na”? (17 Ci/ng; 1 Ci= 37 x 
10” Bq) was obtained from New England Nuclear. 
The following reagents were used: denatured 
human serum albumin (Centre National de Trans- 
fusion Sanguine, Paris) and the selective nzymatic 
inhibitor, Antagosan (aprotinin, 2500 units anti- 
plasmin co~es~ndi~ to 100000 KIUllO ml 
(Hoechst, France)). The following peptide hor- 
mones were used: purified porcine VIP (V. Mutt, 
Stockholm), l-34 PTH synthetic (Touzart& Matig- 
non, Paris), TRH (CEA, Saclay, France), Met- 
Enk (Peninsula, Belmont, CA), neurotensin 1-13 
(J. Van Rietschoten, Marseille), hCT (Ciba, Swit- 
zerland), pCT (Armoor, USA). 
Abbreviations: pCT, synthetic pig CT; hCT, synthetic 
human CT; VIP, vasoactive intestinal peptide; l-34 
PTH, parathyrine; TRH, th~otropin-relying hor- 
mone; CCK, chol~sto~m~-8; Met-Enk, met-enkepha- 
lin; NT, neurotensin 
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2.2. In vitro incubation and autoradiography 
Male Wistar CF rats weighing 200-250 g were 
killed and kidneys removed, frozen and 20pm sec- 
tions were cut on a cryostat at - 18’C, mounted 
on gelatin-coated slides, stored overnight at - 20°C 
and then kept at - 80°C until assayed. The slides 
were warmed at room temperature and incubated 
in 50 mM Tris-HCl buffer (pH 7.6) containing 1% 
denatured human albumin and 10% of Antagosan 
in the presence of 0.07 nm 1251-sCT. Three sets of 
incubations were carried out. First, kidney sections 
were incubated with r2’I-sCT for various times, 
from 10 to 120 min to determine the optimum in- 
cubation time in the presence or absence of lo-’ M 
unlabelled salmon calcitonin. Second, sections 
were incubated with 1251-sCT together with in- 
creasing concentrations of unlabelled sCT ranging 
from lo-*’ to 10m6 M. Third, the radiolabelled 
peptide was incubated in the presence of various 
peptides ranging from 2x lo-” to 2x lo-’ M to 
check the binding specificity and cross-reactivity. 
After incubation, the sections were washed 4 times 
with 40 mM Tris-HCl, pH 7.6, at 4°C for 2 min 
each. This washing procedure was found to give 
the best ratio between total and non-specific bind- 
ing. The sections were removed from the slides 
with Whatman GF/B filter paper and placed in 
plastic tubes for counting (counting efficiency 
5Ooro). 
2.3. Quantitative autoradiography 
Sections treated as previously described were 
then dipped in distilled water and dried with cold 
air. Autoradiographs were prepared by a modifica- 
tion of the method of Rostbne and Mourre [12] 
which facilitated quantitative absorbance measure- 
ments. The sections were placed in contact with 
[3H]Ultrofilm (LKB) in Kodax X-ray film holders 
for 12 days at room temperature. The film was 
then developed and the density of the enlarged 
autoradiographic image measured using a densito- 
meter which converts the amount of light into 
millivolts. The amount of “‘1-sCT-binding sites 
expressed as fmol/mg protein was measured by 
means of “‘1 standards [12]. Proteins were mea- 
sured by the method of Bradford [ 131. Non- 
specific binding was calculated from the amount of 
1251-sCT bound in the presence of excess (lo-’ M) 
unlabelled sCT. Results are expressed as means + 
SE. 
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Fig. 1. Binding of monoiodo salmon calcitonin (‘*‘I- 
sCT) to rat kidney sections. Sections were incubated 
with 0.07 nm ‘2’I-sCT alone (T) or in the presence of 
lo-’ M unlabelled sCT (NSp). Specific binding (Sp) was 
determined as the difference between T and NSp. Each 
point is the mean of 3 determinations. 
3. RESULTS 
3.1. In vitro binding of lZSI-sCT on sections 
3.1.1. Binding optimization 
Incubation of 1251-sCT with rat kidney sections 
reached equilibrium after 60 min at room tempera- 
ture (fig.1). A routine incubation time of 75 min 
was then adopted for all subsequent experiments. 
Increasing concentrations of unlabelled sCT result- 
ed in a dose-dependent displacement of 1251-sCT 
from the sections (fig.2). Maximum displacement 
was obtained with lo-’ M sCT, equivalent to 
8085% of the total 1251-sCT binding. Scatchard 
analysis [14] showed that under our experimental 
conditions, 1251-sCT bound to a single class of 
binding sites with a dissociation constant of 
2.1 kO.2 x 10m9 M and a number of binding sites 
of 218* 22 fmol/mg protein for 3 different 
experiments. 
Two analogues of sCT, pig and human CT, were 
weak competitors for the 1251-sCT-binding sites 
(fig.2). Other peptides which are unrelated to sCT 
showed no ability to displace 1251-sCT (fig.2). 
3.1.2. Autoradiographic studies 
‘251-sCT-binding sites were mainly concentrated 
in the outer medulla. High densities of “‘1-sCT- 
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Fig.2. Displacement of ‘251-sCT by unlabelled peptides 
on rat kidney sections. Results were expressed as the 
percentage of the initial binding. Each point is the mean 
f SE of 3 determinations. 
binding sites were observed in the inner zone par- 
ticularly rich in thick ascending limb segments and 
thin descending limb of the loop of Henle, as well 
as in the outer zone containing the thick ascending 
limb and the pars recta. Moderate amounts of 
binding sites were obtained in the medial part of 
the outer medulla. Fairly intense labelling of 
binding sites was also observed in the cortex but 
the label distribution in this part of the kidney was 
somewhat patchy and mainly concentrated in the 
superficial zone (fig.3A, table 1). 
In the presence of an excess of unlabell~ sCT, 
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Fig.3. Autoradiograms of rat kidney sections (20 pm). 
RC, renal cortex; CM, outer medulla; IM, inner 
medulla; P, papilla. (A) Kidney sections incubated with 
0.07 nM lz51-sCT alone; (B) kidney sections incubated 
tvith 0.07 nM “‘1-sCT in the presence of lo-’ M 
unlabelled sCT. Binding conditions and procedures were 
as described in the text. ~nsitorn~~c values obtained 
from the autoradiograms are reported in table 1. 
Table 1 
Localization and concentration of ‘251-sCT-binding sites in rat kidney sections 
Structures ‘2SI-sCT-binding sites 
(fmol/mg protein) 
Cortex 
Outer medulla 
Inner medulla 
Papilla 
PCT, DCT, CCT (superficial cortex) 
cortical (TAL) 
outer zone (TAL, pars recta) 
middle zone (pars recta, TDL, TAL) 
inner zone (TDL, TAL) 
thin ascending limb 
- 
17.26 f 3.26 
8.52 f 0.98 
34.07 f 1.88 
17.25 f 1.43 
44.60 f 2.08 
2.49 f 0.21 
N.D. 
Concentrations expressed as specific binding were measured by quantitative 
autoradiography (for details ee section 2). PCT, proximal convoluted tubule; DCT, 
distal convoluted tubule; CCT, cortical collecting tubule; TAL, thick ascending limb; 
TDL, thin descending limb; N.D., non-detectable 
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the labelling almost disappeared from all levels 
with the exception of the juxtaglomerular region 
p~ti~ul~ly rich in convoluted proximal tubules 
(fig3B). 
4. DISCUSSION 
Previous experiments how that ‘251-sCT retains 
full biological activity [2-S] and thus can be used 
for identifying physiologi~ly relevant renal recep- 
tor sites in rat kidney. The in situ labelling with 
1251-sCT is highly specific since incubation in the 
presence of an excess of unlabelled ligand results in 
a displacement of 85% of the labelled ligand, while 
no change is observed in the presence of peptides 
such as PTH, TRH, CCK, VIP, Met-Enk and NT. 
The results are in agreement with the specificity of 
sCT-binding sites previously observed with mem- 
brane preparations from rat kidney [2]. Further- 
more, the displacement of labelled salmon 
calcitonin by u~a~lled salmon calcitonin was 
much higher than that observed with mammalian 
calcitonin, such as pig or human, a factor which is 
consistent with the higher biological potency of the 
fish hormone as compared to mammalian hor- 
mones [2]. Under our conditions, pig CT seems to 
be more potent than human CT to displace 12’1- 
sCT binding. The topographical distribution of 
calcitonin-binding sites in the rat kidney as report- 
ed here is in agreement with previous observations 
based on calcitonin-sensitive adenylate cyclase ac- 
tivity and ion transport in the different parts of the 
renal tubule. The homogeneous labelling in the 
outer medulla is likely to correspond to binding to 
the thick ascending limb of the loop of Henle, 
where calcitonin stimulates adenylate cyclase ac- 
tivity, both in the rat and the rabbit [6,7]. In the 
cortex, the heterogeneous labelling represents 
binding to the cortical part of the loop of Henle, 
probably to cells of the distal and collecting cor- 
tical tubules. Adenylate cyclase activity is 
stimulated by calcitonin in all these tubular 
segments in the rat [ 151. The non-specific labelling 
noted in the juxtaglomerular egion which is par- 
ticularly rich in convoluted proximal tubules, cor- 
responds to an area where calcitonin has no 
physiological action [7]. 
We have thus demonstrated that “‘1-sCT may 
be used for studies on the nature and distribution 
of c~~tonin-bindi~ sites in rat kidney sections. 
22 
While this initial study was performed on normal 
kidney tissue, there is every indication that we can 
adopt the same approach for the study of sCT- 
binding sites in a wide variety of physiological and 
pathological conditions related to changes in 
plasma CT concentrations. 
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